We assumed that the TNFα gene polymorphism may affect the production and expression of proinflammatory cytokines (IL-1α, IL-1β, IL-6, TNFα, IFNγ) and CRP in patients with MetS. The gene discussed is CRP; the disease is metabolic syndrome.